141 related articles for article (PubMed ID: 9573038)
1. Examination of ferrochelatase mutations that cause erythropoietic protoporphyria.
Sellers VM; Dailey TA; Dailey HA
Blood; 1998 May; 91(10):3980-5. PubMed ID: 9573038
[TBL] [Abstract][Full Text] [Related]
2. Haplotype analysis of families with erythropoietic protoporphyria and novel mutations of the ferrochelatase gene.
Wang X; Yang L; Kurtz L; Lichtin A; DeLeo VA; Bloomer J; Poh-Fitzpatrick MB
J Invest Dermatol; 1999 Jul; 113(1):87-92. PubMed ID: 10417624
[TBL] [Abstract][Full Text] [Related]
3. Mutations in the iron-sulfur cluster ligands of the human ferrochelatase lead to erythropoietic protoporphyria.
Schneider-Yin X; Gouya L; Dorsey M; Rüfenacht U; Deybach JC; Ferreira GC
Blood; 2000 Aug; 96(4):1545-9. PubMed ID: 10942404
[TBL] [Abstract][Full Text] [Related]
4. Molecular characterization of a ferrochelatase gene defect causing anomalous RNA splicing in erythropoietic protoporphyria.
Sarkany RP; Whitcombe DM; Cox TM
J Invest Dermatol; 1994 Apr; 102(4):481-4. PubMed ID: 8151124
[TBL] [Abstract][Full Text] [Related]
5. Erythropoietic protoporphyria: four novel frameshift mutations in the ferrochelatase gene.
Wang X; Piomelli S; Peacocke M; Christiano AM; Poh-Fitzpatrick MB
J Invest Dermatol; 1997 Nov; 109(5):688-91. PubMed ID: 9347801
[TBL] [Abstract][Full Text] [Related]
6. Human erythropoietic protoporphyria: identification of a mutation at the splice donor site of intron 7 causing exon 7 skipping of the ferrochelatase gene.
Nakahashi Y; Miyazaki H; Kadota Y; Naitoh Y; Inoue K; Yamamoto M; Hayashi N; Taketani S
Hum Mol Genet; 1993 Jul; 2(7):1069-70. PubMed ID: 8364548
[No Abstract] [Full Text] [Related]
7. Systematic analysis of molecular defects in the ferrochelatase gene from patients with erythropoietic protoporphyria.
Rüfenacht UB; Gouya L; Schneider-Yin X; Puy H; Schäfer BW; Aquaron R; Nordmann Y; Minder EI; Deybach JC
Am J Hum Genet; 1998 Jun; 62(6):1341-52. PubMed ID: 9585598
[TBL] [Abstract][Full Text] [Related]
8. A novel mutation in the ferrochelatase gene associated with erythropoietic protoporphyria.
Imoto S; Tanizawa Y; Sato Y; Kaku K; Oka Y
Br J Haematol; 1996 Jul; 94(1):191-7. PubMed ID: 8757534
[TBL] [Abstract][Full Text] [Related]
9. Molecular defect in human erythropoietic protoporphyria with fatal liver failure.
Nakahashi Y; Miyazaki H; Kadota Y; Naitoh Y; Inoue K; Yamamoto M; Hayashi N; Taketani S
Hum Genet; 1993 May; 91(4):303-6. PubMed ID: 8500787
[TBL] [Abstract][Full Text] [Related]
10. Modulation of the phenotype in dominant erythropoietic protoporphyria by a low expression of the normal ferrochelatase allele.
Gouya L; Deybach JC; Lamoril J; Da Silva V; Beaumont C; Grandchamp B; Nordmann Y
Am J Hum Genet; 1996 Feb; 58(2):292-9. PubMed ID: 8571955
[TBL] [Abstract][Full Text] [Related]
11. A new ferrochelatase mutation combined with low expression alleles in a Japanese patient with erythropoietic protoporphyria.
Yasui Y; Muranaka S; Tahara T; Shimizu R; Watanabe S; Horie Y; Nanba E; Uezato H; Takamiyagi A; Taketani S; Akagi R
Clin Sci (Lond); 2002 May; 102(5):501-6. PubMed ID: 11980567
[TBL] [Abstract][Full Text] [Related]
12. Molecular characterization of a novel defect occurring de novo associated with erythropoietic protoporphyria.
Wang X
Biochim Biophys Acta; 1996 Aug; 1316(3):149-52. PubMed ID: 8781532
[TBL] [Abstract][Full Text] [Related]
13. Ferrochelatase.
Ferreira GC
Int J Biochem Cell Biol; 1999 Oct; 31(10):995-1000. PubMed ID: 10582332
[TBL] [Abstract][Full Text] [Related]
14. Mutations in the ferrochelatase gene of four Spanish patients with erythropoietic protoporphyria.
Gouya L; Schneider-Yin X; Rüfenacht U; Herrero C; Lecha M; Mascaro JM; Puy H; Deybach JC; Minder EI
J Invest Dermatol; 1998 Sep; 111(3):406-9. PubMed ID: 9740232
[TBL] [Abstract][Full Text] [Related]
15. Human ferrochelatase: a novel mutation in patients with erythropoietic protoporphyria and an isoform caused by alternative splicing.
Schneider-Yin X; Schäfer BW; Tönz O; Minder EI
Hum Genet; 1995 Apr; 95(4):391-6. PubMed ID: 7705834
[TBL] [Abstract][Full Text] [Related]
16. Molecular defects in erythropoietic protoporphyria with terminal liver failure.
Schneider-Yin X; Schäfer BW; Möhr P; Burg G; Minder EI
Hum Genet; 1994 Jun; 93(6):711-3. PubMed ID: 8005600
[TBL] [Abstract][Full Text] [Related]
17. Erythropoietic protoporphyria: identification of novel mutations in the ferrochelatase gene and comparison of biochemical markers versus molecular analysis as diagnostic strategies.
Frank J; Nelson J; Wang X; Yang L; Ahmad W; Lam H; Jugert FK; Kalka K; Poh-Fitzpatrick MB; Goerz G; Merk HF; Christiano AM
J Investig Med; 1999 Jul; 47(6):278-84. PubMed ID: 10431482
[TBL] [Abstract][Full Text] [Related]
18. Screening for ferrochelatase mutations: molecular heterogeneity of erythropoietic protoporphyria.
Wang X; Poh-Fitzpatrick M; Taketani S; Chen T; Piomelli S
Biochim Biophys Acta; 1994 Jan; 1225(2):187-90. PubMed ID: 8280787
[TBL] [Abstract][Full Text] [Related]
19. Inheritance in erythropoietic protoporphyria: a common wild-type ferrochelatase allelic variant with low expression accounts for clinical manifestation.
Gouya L; Puy H; Lamoril J; Da Silva V; Grandchamp B; Nordmann Y; Deybach JC
Blood; 1999 Mar; 93(6):2105-10. PubMed ID: 10068685
[TBL] [Abstract][Full Text] [Related]
20. The ferrochelatase gene structure and molecular defects associated with erythropoietic protoporphyria.
Taketani S; Fujita H
J Bioenerg Biomembr; 1995 Apr; 27(2):231-8. PubMed ID: 7592570
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]